NZ743656A - Methods of treating a tauopathy - Google Patents

Methods of treating a tauopathy

Info

Publication number
NZ743656A
NZ743656A NZ743656A NZ74365614A NZ743656A NZ 743656 A NZ743656 A NZ 743656A NZ 743656 A NZ743656 A NZ 743656A NZ 74365614 A NZ74365614 A NZ 74365614A NZ 743656 A NZ743656 A NZ 743656A
Authority
NZ
New Zealand
Prior art keywords
tauopathy
treating
methods
formulation
endotoxins
Prior art date
Application number
NZ743656A
Inventor
Irene Griswold-Prenner
Nancy E Stagliano
Vu Dang
Hussain Sami
Michelle BRIGHT Jessica
Original Assignee
Ipierian Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2013/055203 external-priority patent/WO2014028777A2/en
Application filed by Ipierian Inc filed Critical Ipierian Inc
Publication of NZ743656A publication Critical patent/NZ743656A/en

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Disclosed is a pharmaceutical formulation comprising a humanised anti-Tau antibody for treating a tauopathy, wherein the formulation is free of endotoxins.
NZ743656A 2013-06-10 2014-06-09 Methods of treating a tauopathy NZ743656A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201361833355P 2013-06-10 2013-06-10
PCT/US2013/055203 WO2014028777A2 (en) 2012-08-16 2013-08-15 Methods of treating a tauopathy
US14/092,539 US8926974B2 (en) 2012-08-16 2013-11-27 Methods of treating a tauopathy
NZ63057314 2014-06-09

Publications (1)

Publication Number Publication Date
NZ743656A true NZ743656A (en) 2023-01-27

Family

ID=85323534

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ743656A NZ743656A (en) 2013-06-10 2014-06-09 Methods of treating a tauopathy

Country Status (1)

Country Link
NZ (1) NZ743656A (en)

Similar Documents

Publication Publication Date Title
PH12018500894A1 (en) Aqueous pharmaceutical formulation comprising anti-pd-l1 antibody avelumab
EA201591750A1 (en) ANTIBODIES AGAINST B7-H4 AND IMMUNOCONJUGATES
MX2016008098A (en) Bispecific her2 antibodies and methods of use.
EA201500995A1 (en) BISPECIFIC ANTIBODIES, SPECIFIC FOR THE FAP AND DR5, ANTIBODIES, THE SPECIFIC FOR THE DR5, AND METHODS OF THEIR APPLICATION
BR112016019871A2 (en) anti-cd38 antibodies for the treatment of acute lymphoblastic leukemia
BR112017001588A2 (en) cdh6 antibody / drug conjugates
MX2019015604A (en) Methods of treating a tauopathy.
PH12016502061A1 (en) Novel antii-rnf43 antibodies and methods of use
EA201400754A3 (en) NEW PHOSPHATE COMPOUNDS, METHOD OF THEIR PRODUCTION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
FI20135770A (en) Process for the preparation of hydrocarbons
UY35394A (en) PROCESSES FOR THE PREPARATION OF AN APOPTOSIS INDUCTIVE AGENT
MX2015002487A (en) Process for the preparation of teneligliptin.
MX2023006416A (en) Antibodies, uses & methods.
EA201790982A1 (en) SYNTHESIS OF KOPANLISIB AND ITS DIHYDROCHLORIDE
EP3006465A4 (en) Anti-vegf antibody, and pharmaceutical composition for preventing, diagnosing or treating cancer or angiogenesis-related diseases, containing same
EA201790312A1 (en) COMBINATION OF MEDICINES FOR THE TREATMENT OF MULTIPLE MYELOMA
CL2015002358A1 (en) Bicyclic compounds.
HUE040536T2 (en) Process for the preparation of halogen-n, n-dimethylbenzylamines
WO2014155259A3 (en) Process for preparation of rivaroxaban
MX2016003248A (en) Methods of using anti-lgr5 antibodies.
EA201691036A1 (en) NEW CONNECTION FOR THE TREATMENT OF HEAVY HYPOGLYCEMIA
EA201690914A1 (en) NEW CONNECTION FOR THE TREATMENT OF HEAVY HYPOGLYCEMIA
EP3047857A4 (en) Treatment for hemorrhagic diseases by anti-protein-c antibody
NZ743656A (en) Methods of treating a tauopathy
IN2013CH05395A (en)

Legal Events

Date Code Title Description
PSEA Patent sealed
LAPS Patent lapsed